Smallpox Treatments
Find Smallpox Treatments
Brand Name
Tpoxx
Generic Name
Tecovirimat
View Brand Information FDA approval date: August 31, 2018
Classification: Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor
Form: Injection, Capsule
What is Tpoxx (Tecovirimat)?
TPOXX is an inhibitor of the orthopoxvirus VP37 envelope wrapping protein and is indicated for the treatment of human smallpox disease in adults and pediatric patients weighing at least 3 kg.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
European Randomised Clinical Trial on mPOX Infection
Summary: The goal of this randomized controlled double-blind clinical trial is to test the drug tecovirimat in patients with mpox (previously known as monkeypox) disease. The main questions it aims to answer are: * Is tecovirimat effective in treating mpox infection. * Is tecovirimat safe to treat patients with mpox infection. Participants will receive either the drug tecovirimat orally, 600 mg twice per d...